Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
41.88
+1.46 (3.61%)
At close: May 12, 2025, 4:00 PM
40.27
-1.61 (-3.84%)
After-hours: May 12, 2025, 6:03 PM EDT
Revolution Medicines Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
534
Market Cap
7.80B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
RVMD News
- 5 days ago - Revolution Medicines, Inc. (RVMD) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Revolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate Progress - GlobeNewsWire
- 12 days ago - Revolution Medicines to Report Financial Results for First Quarter 2025 After Market Close on May 7, 2025 - GlobeNewsWire
- 14 days ago - Why Is Cancer Drug Developer Revolution Medicines Stock Trading Higher On Monday? - Benzinga
- 15 days ago - Revolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small Cell Lung Cancer at the 2025 AACR Annual Meeting - GlobeNewsWire
- 5 weeks ago - Revolution Medicines to Deliver Multiple Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting - GlobeNewsWire
- 6 weeks ago - Revolution Medicines to Participate in April 2025 Investor Conferences - GlobeNewsWire
- 2 months ago - Revolution Medicines, Inc. (RVMD) Q4 2024 Earnings Call Transcript - Seeking Alpha